blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4347654

EP4347654 - T CELL ENGAGER MOLECULES AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.03.2024
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  09.12.2022
Formerunknown
Status updated on  08.07.2022
Most recent event   Tooltip08.08.2024Change: Validation statespublished on 11.09.2024 [2024/37]
08.08.2024Change - extension statespublished on 11.09.2024 [2024/37]
Applicant(s)For all designated states
Amgen Research (Munich) GmbH
Staffelseestrasse 2
81477 München / DE
For all designated states
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320 / US
[2024/15]
Inventor(s)01 / BROZY, Johannes
81477 Munich / DE
02 / DAHLHOFF, Christoph
81477 Munich / DE
03 / RAUM, Tobias
81477 Munich / DE
04 / PENDZIALEK, Jochen, S.
81477 Munich / DE
05 / WINKEL, Lisa
81477 Munich / DE
06 / MUENZ, Markus
81477 Munich / DE
07 / PIERCE, Nathan, William
Thousand Oaks, California 91320-1799 / US
08 / KIELCZEWSKA, Agnieszka
Thousand Oaks, California 91320-1799 / US
09 / CHEN, Wentao
Thousand Oaks, California 91320-1799 / US
10 / BATES, Darren, L.
Thousand Oaks, California 91320-1799 / US
11 / BLUEMEL, Claudia
81477 Munich / DE
12 / HONER, Jonas, Karl-Josef
81477 Munich / DE
 [2024/15]
Representative(s)Lau, Sarah Jane, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2024/15]
Application number, filing date22734448.802.06.2022
[2024/15]
WO2022US32006
Priority number, dateUS202163197265P04.06.2021         Original published format: US 202163197265 P
US202163236547P24.08.2021         Original published format: US 202163236547 P
[2024/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022256559
Date:08.12.2022
Language:EN
[2022/49]
Type: A1 Application with search report 
No.:EP4347654
Date:10.04.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 08.12.2022 takes the place of the publication of the European patent application.
[2024/15]
Search report(s)International search report - published on:EP08.12.2022
ClassificationIPC:C07K16/28, C07K16/30, A61P35/00
[2024/15]
CPC:
C07K16/28 (EP,IL); C07K16/2866 (EP,IL,KR); A61P35/00 (EP,IL,KR);
C07K16/2803 (EP,IL); C07K16/2809 (EP,IL,KR); C07K16/2818 (KR);
C07K16/2827 (KR); C07K16/2887 (EP,IL); C07K16/30 (EP,IL);
A61K2039/505 (KR); C07K2317/31 (EP,IL,KR); C07K2317/33 (EP,IL,KR);
C07K2317/34 (EP,IL); C07K2317/52 (EP,IL); C07K2317/55 (EP,IL,KR);
C07K2317/622 (EP,IL,KR); C07K2317/73 (EP,IL); C07K2317/732 (KR);
C07K2317/92 (EP,IL,KR); C07K2317/94 (EP,IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/15]
TitleGerman:T-ZELL-ENGAGER-MOLEKÜLE UND VERWENDUNGEN DAVON[2024/15]
English:T CELL ENGAGER MOLECULES AND USES THEREOF[2024/15]
French:MOLÉCULES DE RECRUTEURS DE LYMPHOCYTES T ET LEURS UTILISATIONS[2024/15]
Entry into regional phase28.11.2023National basic fee paid 
28.11.2023Designation fee(s) paid 
28.11.2023Examination fee paid 
Examination procedure28.11.2023Examination requested  [2024/15]
28.11.2023Date on which the examining division has become responsible
09.07.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
19.06.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2016077638  (SLOAN KETTERING INST CANCER [US]);
 [XYI]WO2018072025  (GOVERNING COUNCIL UNIV TORONTO [CA], et al);
 [Y]CN110835371  (PUMISI BIO TECH SUZHOU CO LTD);
 [A]WO2020138489  (SHIONOGI & CO [JP], et al);
by applicantUS6210924
 WO2019140196
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.